Concepedia

Publication | Open Access

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

DOIFull Paper Access

86

Citations

51

References

2004

Year

Nathalie Franchimont, V Putzeys, J. Collette, Séverine Vermeire, P. Rutgeerts, Martine De Vos, A. Van Gossum, Denis Franchimont, René Fiasse, Paul Pelckmans,
Alimentary Pharmacology & Therapeutics

Abstract

Infliximab therapy in Crohn's disease may rapidly influence bone metabolism by acting either on bone formation or bone resorption. This improvement seems to be independent of clinical response to infliximab.

References

YearCitations

Page 1